(Total Views: 57)
Posted On: 04/02/2019 11:55:40 AM
Post# of 74540
$IDRA News Article - Idera Pharmaceuticals Presents ILLUMINATE-101 Data Demonstrating Tilsotolimod Activates Innate and Adaptive Immunity as Monotherapy in Patients with Refractory Solid Tumors at the American Association for Cancer Research (AACR) 2019 Annual Meeting https://marketwirenews.com/news-releases/ider...30290.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
